Straits Times Index
3,187.66 +32.97 (+1.05%) S&P 500
5,022.21 -29.20 (-0.58%) Dow
37,753.31 -45.66 (-0.12%) Nasdaq
15,683.37 -181.88 (-1.15%) Bitcoin USD
62,255.70 -39.70 (-0.06%) CMC Crypto 200
885.54 0.00 (0.00%)
ABT Jan 2025 60.000 call
| Previous close | 51.20 |
| Open | 51.20 |
| Bid | 52.60 |
| Ask | 56.85 |
| Strike | 60.00 |
| Expiry date | 2025-01-17 |
| Day's range | 51.20 - 51.20 |
| Contract range | N/A |
| Volume | |
| Open interest | 19 |
- Yahoo Finance Video
Abbott Labs posts Q1 earnings beat
Abbott Laboratories (ABT) reported first quarter results that topped Wall Street estimates on both the top and bottom lines. The healthcare products company also raised the lower end of its full-year earnings guidance range. Yahoo Finance's Anjalee Khemlani breaks down the results in the video above. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Stephanie Mikulich.
Insider MonkeyAbbott Laboratories (NYSE:ABT) Q1 2024 Earnings Call Transcript
Abbott Laboratories (NYSE:ABT) Q1 2024 Earnings Call Transcript April 17, 2024 Abbott Laboratories isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Robert Ford – Chairman and Chief Executive Officer: Phil Boudreau – Senior Vice President, Finance and Chief Financial Officer: Bob […]
Simply Wall St.Abbott Laboratories First Quarter 2024 Earnings: EPS Beats Expectations
Abbott Laboratories ( NYSE:ABT ) First Quarter 2024 Results Key Financial Results Revenue: US$9.96b (up 2.2% from 1Q...
